Why the study?
Does dietary triglyceride restriction and discontinuation of oral contraceptives reduce plasma triglycerides in a patient with severe hypertriglyceridaemia and LPL/APOA5 mutations?
Does dietary triglyceride restriction and discontinuation of oral contraceptives reduce plasma triglycerides in a patient with severe hypertriglyceridaemia and LPL/APOA5 mutations?
Near-normal triglyceride values can be achieved with a low-fat diet and discontinuation of oral contraceptives in patients with severe hypertriglyceridaemia due to genetic mutations.
Answers are grounded in this paper and cite their sources.
May support low-fat diet plus OC cessation in genetic hypertriglyceridaemia; leaves open prospective validation.
A 44-year-old woman was admitted with pancreatitis caused by hypertriglyceridaemia (fasting triglycerides 28 mmol/L). She used oral contraceptives and ezetimibe 10 mg. She was overweight (body mass index 29.7 kg/m 2 ). Diabetes mellitus was ruled out, as were nephrotic syndrome, alcohol abuse, hypothyroidism and dysbetalipoproteinaemia. Genetic analysis revealed mutations in two genes involved in triglyceride metabolism (apolipoprotein A5 and lipoprotein lipase [LPL]). The LPL activity was 45% compared with pooled healthy controls. The post-heparin triglyceride reduction was 6%, compared with a normal reduction of >20%. The patient was initially treated with gemfibrozil, but this was discontinued due to side effects. Dietary triglyceride restriction and discontinuation of the oral contraceptives lowered the plasma triglycerides within 2 weeks to 3.4 mmol/L. Hypertriglyceridaemia is a risk factor for pancreatitis and cardiovascular disease, and has a broad differential diagnosis including genetic causes. Patients can achieve near-normal triglyceride values with a low-fat diet only.
No takes yet. Share an insight, caveat, or question.
Koopal et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: